Viral-mediated gene delivery for cell-based assays in drug discovery

Bibliography

• Houston JG, Banks MN, Binnie A, et al. Case study: impact of technology investment on lead discovery at Bristol-Myers Squibb, 1998-2006. Drug Discov Today 2008;13:44-51
   PubMed Web of Science ®Google Scholar
• Cawkill D, Eaglestone SS. Evolution of cell-based reagent provision. Drug Discov Today 2007;12:820-5
   PubMed Web of Science ®Google Scholar
• Sewing A, Winchester T, Carnell P, et al. Helping science to succeed: improving processes in R&;D. Drug Discov Today 2008;13:227-33
   PubMed Web of Science ®Google Scholar
• Rees S, Wise A. The industrialisation of cellular screening. Expert Opin Drug Discov 2008;3:715-23
   PubMed Web of Science ®Google Scholar
• Zhang JH, Chung TD, Oldenburg KR. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 1999;4:67-73
   PubMed Web of Science ®Google Scholar
• Lotze MT, Kost TA. Viruses as gene delivery vectors: application to gene function, target validation, and assay development. Cancer Gene Ther 2002;9:692-9
   PubMed Web of Science ®Google Scholar
• Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001;7:33-40
   PubMed Web of Science ®Google Scholar
• Bouard D, Azard-Dany N, Cosset FL. Viral vectors: from virology to transgene expression. Br J Pharmacol 2008
   Google Scholar
• Viral-mediated gene delivery poster. 2008. Available from: http://www.sciencemag.org/products/posters/GeneDeliveryPoster.PDF [Accessed 13 January 2009]
   Google Scholar
• Boyce FM, Bucher NL. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 1996;93:2348-52
   PubMed Web of Science ®Google Scholar
• Michiels F, van EH, van RL, et al. Arrayed adenoviral expression libraries for functional screening. Nat Biotechnol 2002;20:1154-7
   PubMed Web of Science ®Google Scholar
• Arts GJ, Langemeijer E, Tissingh R, et al. Adenoviral vectors expressing siRNAs for discovery and validation of gene function. Genome Res 2003;13:2325-32
   PubMed Web of Science ®Google Scholar
• Yauch RL, Kadel EE III, Nicholas C, et al. Transcriptional-based screens for pathway-specific, high-throughput target discovery in endothelial cells. J Biomol Screen 2004;9:704-11
   PubMed Web of Science ®Google Scholar
• Darrow AL, Conway KA, Vaidya AH, et al. Virus-based expression systems facilitate rapid target in vivo functionality validation and high-throughput screening. J Biomol Screen 2003;8:65-71
   PubMed Web of Science ®Google Scholar
• Johns DG, Ao Z, Naselsky D, et al. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators. Naunyn Schmiedebergs Arch Pharmacol 2004;370:238-50
   PubMed Web of Science ®Google Scholar
• Sorscher EJ, Harris J, Alexander M, et al. Activators of viral gene expression in polarized epithelial monolayers identified by rapid-throughput drug screening. Gene Ther 2006;13:781-8
   PubMed Web of Science ®Google Scholar
• Zhao L, Haslam DB. A quantitative and highly sensitive luciferase-based assay for bacterial toxins that inhibit protein synthesis. J Med Microbiol 2005;54:1023-30
   PubMed Web of Science ®Google Scholar
• Borkow G, Lara HH, yash-Rashkovsky M, et al. Adenovirus expressing a bioluminescence reporter gene and cMAGI cell assay for the detection of HIV-1. Virus Genes 2004;29:257-65
   PubMed Web of Science ®Google Scholar
• Hoyt J, King RW. Adenoviral expression of reporter proteins for high-throughput cell-based screening. Methods Mol Biol 2005;310:187-95
   PubMedGoogle Scholar
• Kost TA, Condreay JP, Mickelson CA. Biosafety and viral gene transfer vectors. Fourth edition. In: Fleming DOHDL, editor, Biological Safety, Principles and Practices, American Society for Microbiology Press, 2006. p. 509-30
   Google Scholar
• Paddison PJ, Silva JM, Conklin DS, et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 2004;428:427-31
   PubMed Web of Science ®Google Scholar
• Berns K, Hijmans EM, Mullenders J, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004;428:431-7
   PubMed Web of Science ®Google Scholar
• Razorenova OV, Ivanov AV, Budanov AV, et al. Virus-based reporter systems for monitoring transcriptional activity of hypoxia-inducible factor 1. Gene 2005;350:89-98
   PubMed Web of Science ®Google Scholar
• Stewart SA, Dykxhoorn DM, Palliser D, et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 2003;9:493-501
   PubMed Web of Science ®Google Scholar
• Ngo VN, Davis RE, Lamy L, et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 2006;441:106-10
   PubMed Web of Science ®Google Scholar
• Royer Y, Menu C, Liu X, et al. High-throughput gateway bicistronic retroviral vectors for stable expression in mammalian cells: exploring the biologic effects of STAT5 overexpression. DNA Cell Biol 2004;23:355-65
   PubMed Web of Science ®Google Scholar
• Buchholz CJ, Duerner LJ, Funke S, et al. Retroviral display and high throughput screening. Comb Chem High Throughput Screen 2008;11:99-110
   PubMed Web of Science ®Google Scholar
• Root DE, Hacohen N, Hahn WC, et al. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat Methods 2006;3:715-9
   PubMed Web of Science ®Google Scholar
• Sumimoto H, Kawakami Y. Lentiviral vector-mediated RNAi and its use for cancer research. Future Oncol 2007;3:655-64
   PubMedGoogle Scholar
• Lesch HP, Turpeinen S, Niskanen EA, et al. Generation of lentivirus vectors using recombinant baculoviruses. Gene Ther 2008;15:1280-6
   PubMed Web of Science ®Google Scholar
• Pluta K, Diehl W, Zhang XY, et al. Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study. BMC Biotechnol 2007;7:41
   PubMed Web of Science ®Google Scholar
• Moffat J, Grueneberg, Yang X, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content sreen. Cell 2006;124:1283-98
   PubMed Web of Science ®Google Scholar
• Borawski J, Lindeman A, Buxton F, et al. Optimization procedure for small interfering RNA transfection in a 384-well format. J Biomol Screen 2007;12:546-59
   PubMed Web of Science ®Google Scholar
• Borghouts C, Kunz C, Groner B. Peptide aptamer libraries. Comb Chem High Throughput Screen 2008;11:135-45
   PubMed Web of Science ®Google Scholar
• de CB, Mikaelian I, Mathieu AL, et al. An antiproliferative genetic screening identifies a peptide aptamer that targets calcineurin and up-regulates its activity. Mol Cell Proteomics 2007;6:451-9
   PubMed Web of Science ®Google Scholar
• Bailey SN, Ali SM, Carpenter AE, et al. Microarrays of lentiviruses for gene function screens in immortalized and primary cells. Nat Methods 2006;3:117-22
   PubMed Web of Science ®Google Scholar
• De La FR, Namkung W, Mills A, et al. Small-molecule screen identifies inhibitors of a human intestinal calcium-activated chloride channel. Mol Pharmacol 2008;73:758-68
   PubMed Web of Science ®Google Scholar
• Tran J, Kung SK. Lentiviral vectors mediate stable and efficient gene delivery into primary murine natural killer cells. Mol Ther 2007;15:1331-9
   PubMed Web of Science ®Google Scholar
• Pan H, Mostoslavsky G, Eruslanov E, et al. Dual-promoter lentiviral system allows inducible expression of noxious proteins in macrophages. J Immunol Methods 2008;329:31-44
   PubMed Web of Science ®Google Scholar
• Kost TA, Condreay JP. Recombinant baculoviruses as expression vectors for insect and mammalian cells. Curr Opin Biotechnol 1999;10:428-33
   PubMed Web of Science ®Google Scholar
• Kost TA, Condreay JP. Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol 2002;20:173-80
   PubMed Web of Science ®Google Scholar
• Kost TA, Condreay JP, Jarvis DL. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 2005;23:567-75
   PubMed Web of Science ®Google Scholar
• Hu YC. Baculovirus vectors for gene therapy. Adv Virus Res 2006;68:287-320
   PubMed Web of Science ®Google Scholar
• Hu YC. Baculoviral vectors for gene delivery: a review. Curr Gene Ther 2008;8:54-65
   PubMed Web of Science ®Google Scholar
• Lu L, Ho Y, Kwang J. Suppression of porcine arterivirus replication by baculovirus-delivered shRNA targeting nucleoprotein. Biochem Biophys Res Commun 2006;340:1178-83
   PubMed Web of Science ®Google Scholar
• Nicholson LJ, Philippe M, Paine AJ, et al. RNA interference mediated in human primary cells via recombinant baculoviral vectors. Mol Ther 2005;11:638-44
   PubMed Web of Science ®Google Scholar
• Suzuki H, Kaneko H, Tamai N, et al. Suppression of HCV RNA replication by baculovirus-mediated shRNA expression. Nucleic Acids Symp Ser (Oxf) 2005;49:339-40
   PubMedGoogle Scholar
• Kost TA, Condreay JP, Ames RS, et al. Implementation of BacMam virus gene delivery technology in a drug discovery setting. Drug Discov Today 2007;12:396-403
   PubMed Web of Science ®Google Scholar
• Condreay JP, Ames RS, Hassan NJ, et al. Baculoviruses and mammalian cell-based assays for drug screening. Adv Virus Res 2006;68:255-86
   PubMed Web of Science ®Google Scholar
• Ames R, Fornwald J, Nuthulaganti P, et al. BacMam recombinant baculoviruses in G protein-coupled receptor drug discovery. Receptors Channels 2004;10:99-107
   PubMedGoogle Scholar
• Ames RS, Kost TA, Condreay JP. BacMam technology and its application to drug discovery. Expert Opin Drug Discov 2007;2:1669-81
   PubMed Web of Science ®Google Scholar
• Boudjelal M, Mason SJ, Katso RM, et al. The application of BacMam technology in nuclear receptor drug discovery. Biotechnol Annu Rev 2005;11:101-25
   PubMedGoogle Scholar
• Ames R, Nuthulaganti P, Fornwald J, et al. Heterologous expression of G protein-coupled receptors in U-2 OS osteosarcoma cells. Receptors Channels 2004;10:117-24
   PubMedGoogle Scholar
• Medhurst AD, Atkins AR, Beresford IJ, et al. GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models. J Pharmacol Exp Ther 2007;321:1032-45
   PubMed Web of Science ®Google Scholar
• Behm DJ, Stankus G, Doe CP, et al. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems. Br J Pharmacol 2006;148:173-90
   PubMed Web of Science ®Google Scholar
• Briscoe CP, Peat AJ, McKeown SC, et al. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br J Pharmacol 2006;148:619-28
   PubMed Web of Science ®Google Scholar
• Kenakin T, Jenkinson S, Watson C. Determining the potency and molecular mechanism of action of insurmountable antagonists. J Pharmacol Exp Ther 2006;319:710-23
   PubMed Web of Science ®Google Scholar
• Watson C, Jenkinson S, Kazmierski W, et al. The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor. Mol Pharmacol 2005;67:1268-82
   PubMed Web of Science ®Google Scholar
• Jenkinson S, McCoy DC, Kerner SA, et al. Development of a novel high-throughput surrogate assay to measure HIV envelope/CCR5/CD4-mediated viral/cell fusion using BacMam baculovirus technology. J Biomol Screen 2003;8:463-70
   PubMed Web of Science ®Google Scholar
• Magga J, Bart G, Oker-Blom C, et al. Agonist potency differentiates G protein activation and Ca2+ signalling by the orexin receptor type 1. Biochem Pharmacol 2006;71:827-36
   PubMed Web of Science ®Google Scholar
• Hoffman AF, Garippa RJ. A pharmaceutical company user's perspective on the potential of high content screening in drug discovery. Methods Mol Biol 2007;356:19-31
   PubMedGoogle Scholar
• Pfohl JL, Worley JF III, Condreay JP, et al. Titration of KATP channel expression in mammalian cells utilizing recombinant baculovirus transduction. Receptors Channels 2002;8:99-111
   PubMedGoogle Scholar
• Gunthorpe MJ, Hannan SL, Smart D, et al. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that tnhibits the capsaicin-, acid-, and heat-mediated activation of the receptor. J Pharmacol Exp Ther 2007;321:1183-92
   PubMed Web of Science ®Google Scholar
• Fonfria E, Clay WC, Levy DS, et al. Cloning and pharmacological characterization of the guinea pig P2X7 receptor orthologue. Br J Pharmacol 2008;153:544-56
   PubMed Web of Science ®Google Scholar
• Clay WC, Condreay JP, Moore LB, et al. Recombinant baculoviruses used to study estrogen receptor function in human osteosarcoma cells. Assay Drug Dev Technol 2004;1:801-10
   Web of Science ®Google Scholar
• Katso RM, Parham JH, Caivano M, et al. Evaluation of cell-based assays for steroid nuclear receptors delivered by recombinant baculoviruses. J Biomol Screen 2005;10:715-24
   PubMed Web of Science ®Google Scholar
• Hassan NJ, Pountney DJ, Ellis C, et al. BacMam recombinant baculovirus in transporter expression: a study of BCRP and OATP1B1. Protein Expr Purif 2006;47:591-8
   PubMed Web of Science ®Google Scholar
• Wang DY, Lu Q, Walsh SL, et al. Development of a high-throughput cell-based assay for 11beta-hydroxysteroid dehydrogenase type 1 using BacMam technology. Mol Biotechnol 2008;39:127-34
   PubMed Web of Science ®Google Scholar
• Wang QZ, Lv YH, Diao Y, et al. The design of vectors for RNAi delivery system. Curr Pharm Des 2008;14:1327-40
   PubMed Web of Science ®Google Scholar
• Mizuguchi H, Kay MA, Hayakawa T. Approaches for generating recombinant adenovirus vectors. Adv Drug Deliv Rev 2001;52:165-76
   PubMed Web of Science ®Google Scholar
• Cockrell AS, Kafri T. Gene delivery by lentivirus vectors. Mol Biotechnol 2007;36:184-204
   PubMed Web of Science ®Google Scholar
• Schaffer DV, Koerber JT, Lim KI. Molecular engineering of viral gene delivery vehicles. Annu Rev Biomed Eng 2008;10:169-94
   PubMed Web of Science ®Google Scholar
• Geisse S. Insect cell cultivation and generation of recombinant baculovirus particles for recombinant protein production. In: Animal Cell Biotechnology: Methods and Protocols, 24th edition; Pörtner R (editor). 2007. p. 489-507
   Google Scholar
• Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998;72:8463-71
   PubMed Web of Science ®Google Scholar
• Ma Q, Zhou L, Ma L, et al. Directional and direct cloning strategy for high-throughput generation of recombinant baculoviruses. BioTechniques 2006;41:453-8
   PubMed Web of Science ®Google Scholar
• Sukman AJ, Kallarakal A, Fornwald J, et al. Generation of recombinant adenovirus vectors by a direct cloning approach. In: Gene cloning and expression technologies. Lu Q, Weiner MP, (editors), Eaton Publishing. 2002. p. 341-55
   Google Scholar
• Kaba SA, Salcedo AM, Wafula PO, et al. Development of a chitinase and v-cathepsin negative bacmid for improved integrity of secreted recombinant proteins. J Virol Methods 2004;122:113-8
   PubMed Web of Science ®Google Scholar
• Banaszynski LA, Chen LC, Maynard-Smith LA, et al. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 2006;126:995-1004
   PubMed Web of Science ®Google Scholar
• Jarvis DL, Garcia A Jr. Long-term stability of baculoviruses stored under various conditions. BioTechniques 1994;16:508-13
   PubMed Web of Science ®Google Scholar
• Tsai CT, Chan ZR, Lu JT, et al. Factors influencing the production and storage of baculovirus for gene delivery: An alternative perspective from the transducing titer assay. Enzyme Microbiol Technol 2007;40:1345-51
   Web of Science ®Google Scholar
• Braun A. Biosafety in handling gene transfer vectors. Curr Protoc Hum Genet 2006;Chapter 12:Unit.12.1
   PubMedGoogle Scholar
• Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther 2000;7:20-3
   PubMed Web of Science ®Google Scholar
• Kost TA, Condreay JP. Baculovirus vectors as gene transfer vectors for mammalian cells: biosafety considerations. Appl Biosafety 2002;7:167-9
   Google Scholar
• Fontana L, Nuzzo M, Urbanelli L, et al. General strategy for broadening adenovirus tropism. J Virol 2003;77:11094-104
   PubMed Web of Science ®Google Scholar
• Chuang CK, Sung LY, Hwang SM, et al. Baculovirus as a new gene delivery vector for stem cell engineering and bone tissue engineering. 2007;14:1417-24
   Google Scholar
• Zeng J, Du J, Zhao Y, et al. Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells. Stem Cells 2007;25:1055-61
   PubMed Web of Science ®Google Scholar
• Ge J, Huang Y, Hu X, et al. A surface-modified baculovirus vector with improved gene delivery to B-lymphocytic cells. J Biotechnol 2007;129:367-72
   PubMed Web of Science ®Google Scholar
• Organelle Lights™ reagents. 2007. Available from: http://www.invitrogen.com/content.cfm?pageid=11890 [Accessed 13 January 2009]
   Google Scholar
• Available from: www.invitrogen.com
   Google Scholar
• Hu YC, Tsai CT, Chang YJ, et al. Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: focuses on strategic infection and feeding. Biotechnol Prog 2003;19:373-9
   PubMed Web of Science ®Google Scholar
• Condreay JP, Witherspoon SM, Clay WC, et al. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci USA 1999;96:127-32
   PubMed Web of Science ®Google Scholar
• Van DK, Hanahan D, Gluzman Y. Infection of eucaryotic cells by helper-independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA. J Virol 1984;50:606-14
   PubMed Web of Science ®Google Scholar
• Abe T, Hemmi H, Miyamoto H, et al. Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J Virol 2005;79:2847-58
   PubMed Web of Science ®Google Scholar
• Gronowski AM, Hilbert DM, Sheehan KC, et al. Baculovirus stimulates antiviral effects in mammalian cells. J Virol 1999;73:9944-51
   PubMed Web of Science ®Google Scholar
• Grassi G, Kohn H, Dapas B, et al. Comparison between recombinant baculo- and adenoviral-vectors as transfer system in cardiovascular cells. Arch Virol 2006;151:255-71
   PubMed Web of Science ®Google Scholar
• Clesham GJ, Adam PJ, Proudfoot D, et al. High adenoviral loads stimulate NF kappaB-dependent gene expression in human vascular smooth muscle cells. Gene Ther 1998;5:174-80
   PubMed Web of Science ®Google Scholar
• Stilwell JL, Samulski RJ. Role of viral vectors and virion shells in cellular gene expression. Mol Ther 2004;9:337-46
   PubMed Web of Science ®Google Scholar
• Andersson M, Warolen M, Nilsson J, et al. Baculovirus-mediated gene transfer and recombinant protein expression do not interfere with insulin dependent phosphorylation of PKB/Akt in human SHSY-5Y and C3A cells. BMC Cell Biol 2007;8:6
   PubMed Web of Science ®Google Scholar
• Horrocks C, Halse R, Suzuki R, et al. Human cell systems for drug discovery. Curr Opin Drug Discov Devel 2003;6:570-5
   PubMed Web of Science ®Google Scholar
• Hanson GT, Hanson BJ. Fluorescent probes for cellular assays. Comb Chem High Throughput Screen 2008;11:505-13
   PubMed Web of Science ®Google Scholar
• Premo Cameleon calcium sensor. 2008. Available from: http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/Cell-and-Tissue-Analysis/Cellular-Imaging/Cell-Based-Reporter-Assays/Promo_Cameleon_Calcium_Sensor.html [Accessed 13 January 2009]
   Google Scholar
• Jia Y, Gu XJ, Brinker A, et al. Measuring the tyrosine kinase activity: a review of biochemical and cellular assay technologies. Expert Opin Drug Discov 2008;3:959-78
   PubMed Web of Science ®Google Scholar
• TR-FRET assay development. 2008. Available from: http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/Drug-Discovery/Target-and-Lead-Identification-and-Validation/KinaseBiology/Kinase-Activity-Assays/LanthaScreen-TR-FRET-ToolBox/LanthaScreen-TR-FRET-Technology-Overview.html [Accessed 13 January 2009]
   Google Scholar
• Douglas KL. Toward Development of Artificial Viruses for Gene Therapy: a comparative evaluation of viral and non-viral transfection. Biotechnol Prog 2008;24:871-83
   PubMed Web of Science ®Google Scholar